Initial findings from a study looking at the longer-term impact of COVID-19 has found that a large proportion COVID-19 patients discharged from hospital were still experiencing symptoms of breathlessness, fatigue, anxiety and depression two to three months after contracting the virus. The University of Oxford scientists carrying out the C-MORE study have also detected abnormalities […]
A team of mathematical modellers and epidemiologists at Oxford University’s Nuffield Department of Medicine release the latest model of a population responding to the coronavirus epidemic. The model – OpenABM-Covid19 – provides public health decision-makers with the ability to review the potential progression and outcome of the coronavirus, including fluctuations in infected individuals, hospitalisations, intensive care unit […]
Oxford Brookes spinout company Oxford Expression Technologies has been awarded a grant from Innovate UK to support a partnership with Vaxine Pty Ltd to develop a vaccine for COVID-19. The grant will accelerate the creation of the Covax-19® vaccine, which is being developed by Vaxine, an Australian biotechnology company focussing on the development of innovative […]
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), based at Oxford University, in collaboration with Dr Janet Scott, of the MRC-University of Glasgow’s Centre for Virus Research, has launched a longitudinal observational study to measure prevalence and risk factors of long-term health and psycho-social consequences of COVID-19. The researchers are inviting hospitals and […]
A study involving Oxford researchers has found that having had a liver transplant does not increase the risk of death from COVID-19, but that other factors such as age and comorbidities among liver transplant recipients do. The researchers from the Oxford Liver Unit, based at Oxford University Hospitals (OUH) NHS Foundation Trust, and the University of […]
A new arm of the ongoing global clinical trials of the ChAdOx1 nCoV-19 vaccine led by AstraZeneca has launched in the US to assess safety, efficacy and immunogenicity of the vaccine for the prevention of COVID-19. Our vaccine work is progressing quickly. To ensure you have the latest information or to find out more about […]
Oxford Brookes University has been awarded funding to develop four innovative projects which aim to help the UK’s recovery from the coronavirus pandemic. The funding is part of a £40m government investment to fast-track new technology while supporting the UK’s next generation of cutting-edge small businesses. More than 8,600 projects applied for funding of up […]
Volunteers have begun taking part in Latin America’s first clinical trial for a vaccine against COVID-19. Volunteers in Brazil have begun receiving a trial vaccine against COVID-19, in Latin America’s first phase 3 COVID-19 clinical trial. The trial officially began on Saturday 20th June and will enrol 5,000 volunteers across the country. Vaccinations will take […]
The UK regulator MHRA announced on 26 June that it would again permit recruitment to the COPCOV COVID-19 prevention clinical trial. The MHRA decision came 5 weeks after it reacted immediately to the now-discredited paper published in The Lancet suggesting harms with hydroxychloroquine, and paused recruitment of UK participants. But The Lancet paper was based […]
A new type of aerosol shield designed by motor racing engineers to improve the treatment of COVID-19 patients and safety of clinical staff has been approved for use at a leading NHS trust. Staff at Oxford University Hospitals (OUH) NHS Foundation Trust say the new ‘Oxford Box’ could mark a significant breakthrough in the treatment of […]